Autologous HIV-specific CD8+ T cell immunotherapy

HIV-specific CD8+ T cells · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous HIV-specific CD8+ T cell immunotherapy, covering 2008-08-08 to 2008-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults [Phase 1]